NCT03513952 2024-07-26Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial CarcinomaNational Cancer Institute (NCI)Phase 2 Completed47 enrolled 14 charts
NCT01368107 2015-02-09Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer PatientsCentre Leon BerardPhase 2 Completed24 enrolled